title: Regulatory factor X1-induced down-regulation of transforming growth factor β2 transcription in human neuroblastoma cells.
abstract: Regulatory factor X (RFX) proteins are transcription factors. Seven mammalian RFX proteins have been identified. RFX1 is the prototype RFX. However, its biological functions are not known. Here, RFX1 overexpression reduced fetal bovine serum-stimulated proliferation of SH-SY5Y cells, a human neuroblastoma cell line. This inhibition is associated with decreased transforming growth factor β2 (TGFβ2) and phospho-extracellular signal-regulated kinase (ERK). Exogenous TGFβ2 increased cell proliferation and phospho-ERK in cells overexpressing RFX1. An anti-TGFβ2 antibody and PD98059, an ERK activation inhibitor, inhibited SH-SY5Y cell proliferation. TGFβ2 promoter activity was decreased in cells overexpressing RFX1. Chromosome immunoprecipitation assay showed that RFX1 bound the TGFβ2 promoter. RFX1 down-regulation increased TGFβ2 in SH-SY5Y and HCN-1A cells, a normal human neuronal cell line. More importantly, TGFβ2 concentrations were negatively correlated with RFX1 levels in human medulloblastoma tissues with a R(2) of 0.464. These results suggest that RFX1 reduces cell proliferation through inhibiting the TGFβ2-ERK signaling pathway. RFX1 blocks TGFβ2 expression through its direct action on TGFβ2 transcription. This effect also appears in human brain tumor tissues. Because TGFβ is known to be involved in cancer development, our results provide initial evidence to suggest that RFX1 may play an important role in human tumor biology.
authors.affiliation: Department of Anesthesiology, School of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA.
authors.forename: Chenzhuo
authors.initials: C
authors.lastname: Feng
authors.forename: Zhiyi
authors.initials: Z
authors.lastname: Zuo
mesh_terms: D002455:Cell Division / Q000502:physiology; D045744:Cell Line, Tumor; D002528:Cerebellar Neoplasms / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D004268:DNA-Binding Proteins / Q000502:physiology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D008527:Medulloblastoma / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D009447:Neuroblastoma; D009474:Neurons / Q000166:cytology* / Q000502:physiology*; D034741:RNA, Small Interfering / Q000235:genetics; D000071701:Regulatory Factor X Transcription Factors; D000071716:Regulatory Factor X1; D014157:Transcription Factors / Q000502:physiology*; D014158:Transcription, Genetic / Q000502:physiology; D053781:Transforming Growth Factor beta2 / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; C000605537:RFX1 protein, human; D034741:RNA, Small Interfering; D000071701:Regulatory Factor X Transcription Factors; D000071716:Regulatory Factor X1; D014157:Transcription Factors; D053781:Transforming Growth Factor beta2; D048049:Extracellular Signal-Regulated MAP Kinases